Carla Task Force on Sarcopenia: Propositions for clinical trials
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
In the presence of an aging population, public health priorities need to evolve. As the populations gets older, the already existing pathologies have become commonplace with specific geriatric clinical syndromes like frailty, mobility disability, or cognitive impairment, among others. Sarcopenia is a good example for which geriatricians, neurologists, physiologists, nutritionists and epidemiologists need to find a consensual definition and diagnostic tool as well as guidelines for the management of clinical trials and possible treatments. The Carla Sarcopenia Task Force, which met in the south of France (Toulouse) for an expert consensus meeting called "Les Entretiens du Carla", have addressed a series of existing issues to place Sarcopenia into a nosological context: a definition which should be a composite of a change in muscle mass and a change in strength/function depending on either a progressive and chronic wasting process or an acute onset of loss of muscle mass; a recommendation for DXA and the Short Physical Performance Battery as a clinical pragmatic approach of Sarcopenia; a differentiated approach for clinical studies according to prevention or treatment objectives and depending on the sub-groups and target populations; and finally, a summary of therapeutic strategies currently recommended. The aim of "Les Entretiens du Carla", based on an expert meeting panel, was to address a series of unsolved issues in the field of Sarcopenia by combining the expert opinion with a revision of the existing literature on the topic. Through this report, the reader will appreciate the determination to find conclusions on the various issues and further studies to be developed to determine the best multidisciplinary approach needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 2×
“The definition of sarcopenia should be close to the initial Rosenberg definition”
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Houston, D. K., Nicklas, B. J., Ding, J., Harris, T. B., Tylavsky, F. A., Newman, A. B., Lee, J. S., Sahyoun, N. R., Visser, M., & Kritchevsky, S. B. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.150 · Cited by 1,214
Self-citationIncreased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
Volpi, E., Kobayashi, H., Sheffield-Moore, M., Mittendorfer, B., & Wolfe, R. R. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.2.250 · Cited by 846
Häkkinen, K., Kallinen, M., Izquierdo, M., Jokelainen, K., Lassila, H., Mälkiä, E., Kraemer, W. J., Newton, R. U., & Alen, M. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.84.4.1341 · Cited by 776 · cited 1×
“The scarce studies that have reported an increase in strength, the magnitude observed was lower than the increase obtained by resistance training.”
Vitamin D Receptor Expression in Human Muscle Tissue Decreases with Age
Bischoff-Ferrari, H., Borchers, M., Gudat, F., Dürmüller, U., Stähelin, H., & Dick, W. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2004.19.2.265 · Cited by 585 · cited 1×
“This is supported by the presence of the VDR in human muscle tissue (48) and a rapid (49, 50) and sustained (51-54) effect of vitamin D on falls from several trials.”
Self-citationBlackman, M. R. (2002) · JAMA · doi:10.1001/jama.288.18.2282 · Cited by 455
Taaffe, D. R., Duret, C., Wheeler, S., & Marcus, R. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb05201.x · Cited by 426 · cited 1×
“2 Several reports suggested that maintaining the benefits from resistance training is possible with as little as one exercise program per week (9), but organizing resistance training sessions and programs are challenging in frail elderly subjects and some practitioners are reluctant to prescribe high intensity exercis…”
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Onder, G., Penninx, B. W., Balkrishnan, R., Fried, L. P., Chaves, P. H., Williamson, J., Carter, C., Bari, M. D., Guralnik, J. M., & Pahor, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08024-8 · Cited by 339 · cited 1×
“Angiotensin II Converting Enzyme inhibitors (ACE inhibitors)—Growing evidence suggests that ACE inhibitors may prevent sarcopenia (14, 65, 66).”
Self-citationProtein pulse feeding improves protein retention in elderly women
Arnal, M.-A., Mosoni, L., Boirie, Y., Houlier, M.-L., Morin, L., Verdier, E., Ritz, P., Antoine, J.-M., Prugnaud, J., Beaufrère, B., et al. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1202 · Cited by 284
Self-citationPhillips, T., & Leeuwenburgh, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2870fje · Cited by 283 · cited 3×
“For instance, exercise training reverses skeletal muscle apoptosis (77) and caloric restriction reduces apoptosis pathways stimulated by TNF (78).”
Robinson, S. M., Jameson, K. A., Batelaan, S. F., Martin, H. J., Syddall, H. E., Dennison, E. M., Cooper, C., Sayer, A. A., & the Hertfordshire Cohort Study Group (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01478.x · Cited by 282 · cited 1×
“Epidemiological data also suggest that fatty fish consumption rich in the anti inflammatory actions of omega-3 fatty acid may prevent sarcopenia (73).”
Brose, A., Parise, G., & Tarnopolsky, M. A. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.1.b11 · Cited by 274 · cited 1×
“Several mechanisms for this action are hypothesized such as an increased expression of myogenic transcription factors, but the few clinical trials in older people (in addition to physical training or not) reported conflicting results (58-63).”
Heritability of body size and muscle strength in young adulthood: a study of one million Swedish men
Silventoinen, K., Magnusson, P. K. E., Tynelius, P., Kaprio, J., & Rasmussen, F. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20308 · Cited by 261
Effect of growth hormone and resistance exercise on muscle growth and strength in older men
Yarasheski, K. E., Zachwieja, J. J., Campbell, J. A., & Bier, D. M. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.2.e268 · Cited by 234 · cited 1×
“Growth hormone—GH increases muscle strength and mass in young subjects with hypopituitarism, but in older people, who are frequently GH-deficient, most of studies report no increase in muscle mass or strength even if associated with resistance training (16, 32).”
Creatine supplementation combined with resistance training in older men
CHRUSCH, M. J., CHILIBECK, P. D., CHAD, K. E., SHAWN DAVISON, K., & BURKE, D. G. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200112000-00021 · Cited by 233 · cited 1×
“Several mechanisms for this action are hypothesized such as an increased expression of myogenic transcription factors, but the few clinical trials in older people (in addition to physical training or not) reported conflicting results (58-63).”
Association of IGF-I levels with muscle strength and mobility in older women
Cappola, A. R., Bandeen-Roche, K., Wand, G. S., Volpato, S., & Fried, L. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7868 · Cited by 205
Physiopathological mechanism of sarcopenia
Boirie, Y. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0203-x · Cited by 203
Self-citationEstrogen Receptor Alpha mRNA in Human Skeletal Muscles
LEMOINE, S., GRANIER, P., TIFFOCHE, C., RANNOU-BEKONO, F., THIEULANT, M.-L., & DELAMARCHE, P. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000053654.14410.78 · Cited by 201
Sarcopenia: Clinical evaluation, biological markers and other evaluation tools
Pahor, M., Manini, T., & Cesari, M. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0204-9 · Cited by 200
Self-citationAndrogen Treatment and Muscle Strength in Elderly Men: A Meta‐Analysis
Ottenbacher, K. J., Ottenbacher, M. E., Ottenbacher, A. J., Acha, A. A., & Ostir, G. V. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00938.x · Cited by 173
Effects of creatine monohydrate ingestion in sedentary and weight‐trained older adults
BERMON, VENEMBRE, SACHET, VALOUR, & DOLISI (1998) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1998.00427.x · Cited by 165 · cited 1×
“Several mechanisms for this action are hypothesized such as an increased expression of myogenic transcription factors, but the few clinical trials in older people (in addition to physical training or not) reported conflicting results (58-63).”
Creatine supplementation improves muscular performance in older men
GOTSHALK, L. A., VOLEK, J. S., STARON, R. S., DENEGAR, C. R., HAGERMAN, F. C., & KRAEMER, W. J. (2002) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200203000-00023 · Cited by 158 · cited 1×
“Several mechanisms for this action are hypothesized such as an increased expression of myogenic transcription factors, but the few clinical trials in older people (in addition to physical training or not) reported conflicting results (58-63).”
Increased Bone Resorption in Moderate Smokers with Low Body Weight: The Minos Study
Szulc, P. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.666 · Cited by 144 · cited 1×
“Proposition 10: Genes Many genetic factors contribute to muscle mass and strength and treatments based on physiopathology of sarcopenia can be expected in the future.”
Cited by
Nutritional recommendations for the management of sarcopenia
Morley, J. E., Argiles, J. M., Evans, W. J., Bhasin, S., Cella, D., Deutz, N. E. P., Doehner, W., Fearon, K. C. H., Ferrucci, L., Hellerstein, M. K., et al. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.04.014 · Cited by 664
“Pathological sarcopenia is associated with an extremely high rate of disability.(13) In the United States, sarcopenia has been estimated to have an economic burden related to health care expenditures of $18.”
Functional consequences of sarcopenia and dynapenia in the elderly
Clark, B. C., & Manini, T. M. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328337819e · Cited by 359
Bischoff-Ferrari, H. A., Orav, J. E., Kanis, J. A., Rizzoli, R., Schlögl, M., Staehelin, H. B., Willett, W. C., & Dawson-Hughes, B. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3194-y · Cited by 332
“A condition that is considered central to the development of physical disability, frailty, and their consequences are sarcopenia [4, 5, 9, 10, 12–23] and the loss of muscle mass and strength [20, 24].”
BackgroundSelf-citationGet a grip: individual variations in grip strength are a marker of brain health
Carson, R. G. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.023 · Cited by 237
Van Roie, E., Delecluse, C., Coudyzer, W., Boonen, S., & Bautmans, I. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.08.010 · Cited by 178
Metadata
- Authors
- Abellan Van Kan, G., André, E., Bischoff-Ferrari, H. A., Boirie, Y., Onder, G., Pahor, M., Ritz, P., Rolland, Y., Sampaio, C., Studenski, S., Visser, M., & Vellas, B.
- Venue
- The Journal of nutrition, health and aging
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 13
- Issue
- 8
- Pages
- 700-707
- ISSN
- 1279-7707 (ISSN-L)
- OpenAlex
- W2032428449
- Cited by
- 66
- References
- 26
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.